Simplify Medical closed a US $21.0MMÂ Series B financing. Funds will support two ongoing U.S. pivotal clinical trials of the Simplify cervical disc.
Ongoing studies include:
a two-level, prospective pivotal trial a pivotal trial comparing one-level cervical implantation Life Sciences Partners led the round, with additional investment from Sectoral Asset Management and existing investor M.H. Carnegie.
Simplify Disc has received CE Mark approval and has been used to treat >700 patients ex-U.S. over the last three years.
Sources: Simplify Medical ; ORTHOWORLD Inc.
Favorite
Simplify Medical closed a US $21.0MMÂ Series B financing. Funds will support two ongoing U.S. pivotal clinical trials of the Simplify cervical disc.
Ongoing studies include:
a two-level, prospective pivotal trial one-level cervical implantation
Simplify Medical closed a US $21.0MMÂ Series B financing. Funds will support two ongoing U.S. pivotal clinical trials of the Simplify cervical disc.
Ongoing studies include:
a two-level, prospective pivotal trial a pivotal trial comparing one-level cervical implantation Life Sciences Partners led the round, with additional investment from Sectoral Asset Management and existing investor M.H. Carnegie.
Simplify Disc has received CE Mark approval and has been used to treat >700 patients ex-U.S. over the last three years.
Sources: Simplify Medical ; ORTHOWORLD Inc.
Favorite You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
